The combination of tau and amyloid PET imaging will enable accurate diagnosis of AD, early detection of individuals at-risk who have AD neuropathology, and help in understanding when, where, and how tau tangles interact with amyloid plaques in the brain. The gene discussed is MAPT; the disease is amyloidosis.